Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/4/2019
SIETES contiene 92717 citas

 
 
 1 a 20 de 270 siguiente >>
Presentar resultados
Seleccionar todas
3.Enlace a cita original Cita con resumen
Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy. A review. JAMA 2019;321:15 de enero. [Ref.ID 103008]
4.Enlace a cita original Cita con resumen
Mayor S. Pregabalin and gabapentin become controlled drugs to cut deaths from misuse. BMJ 2018;363:16 de octubre. [Ref.ID 102878]
6.Enlace a cita original Cita con resumen
Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer Jr CE, Dees EC, Goetz MP, Olson Jr JA, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MC, Paik S, Wood WC, Ravdin PM, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Tppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge Jr GW. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med 2018;379:111-21. [Ref.ID 102694]
8. Cita con resumen
Bradford AC, Bradford WD. Medical marijuana laws may be associated with a decline in the number of prescriptions for Medicaid enrollees. Health Affairs 2017;36:1 de mayo. [Ref.ID 101570]
10. Cita con resumen
Anónimo. Cannabis and cannabinoids. Med Lett Drugs Ther 2016;58:97-8. [Ref.ID 100510]
11. Cita con resumen
Taylor P, Nutt D, Fortson R, Henderson G, on behalf of DrugScience. Ketamine—the real perspective. Lancet 2016;387:1271-2. [Ref.ID 100277]
12. Cita con resumen
Hampton T. New drug delivery technologies may advance personalized cancer therapy. JAMA 2015;313:2114. [Ref.ID 99118]
14. Cita con resumen
Herman AO. Hydrocodone products to get more severe, schedule II classification. Journal Watch 2014:22 de agosto. [Ref.ID 97860]
16. Cita con resumen
Kelley KJ. FDA proposing tighter restrictions on hydrocodone products. Physician's First Watch 2013:28 de octubre. [Ref.ID 96251]
17. Cita con resumen
Cohen D. European drugs agency clashes with scientists over GLP-1 drugs. BMJ 2013;347:2. [Ref.ID 96152]
18. Cita con resumen
Aubin F, Carbonnel F, Wendling D. The complexity of adverse side-effects to biological agents. Journal of Crohn's and Colitis 2013;7:257-62. [Ref.ID 96072]
19. Cita con resumen
McCarron RM. The DSM-5 and the art of medicine: certainly uncertain. Ann Intern Med 2013;159:360-1. [Ref.ID 96010]
20. Cita con resumen
Granovetter M. Let's talk therapy: treatments for children with autism. Lancet 2013;382:753. [Ref.ID 95997]
Seleccionar todas
 
 1 a 20 de 270 siguiente >>